Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burton

Showing results (781-790 of 1,376) with videos related to

Pageof 138
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Gut|November 30, 2018
Fine needle aspirates comprehensively sample intrahepatic immunityUpkar S Gill, Laura J Pallett, Niclas Thomas, et al.
Journal of Virology|May 28, 2003
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12Michael B Zwick, Robert Kelleher, Richard Jensen, et al.
BMJ Open|August 28, 2016
Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventionsL Williams, J Rycroft-Malone, C R Burton, et al.
European Heart Journal|March 25, 2004
Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control studyMartin D Tobin, Peter S Braund, Paul R Burton, et al.
AIDS Research and Human Retroviruses|February 21, 2008
Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140Suganya Selvarajah, Bridget A Puffer, Fang-Hua Lee, et al.
Cell Reports|March 27, 2023
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2Joel D Allen, Dylan P Ivory, Sophie Ge Song, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2012
Pharmacokinetic interaction between boceprevir and etravirine in HIV/HCV seronegative volunteersKyle P Hammond, Pamela Wolfe, James R Burton, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicityJuan F Arias, Lisa N Heyer, Benjamin von Bredow, et al.
Pageof 138

Showing results (781-790 of 1,376) with videos related to

Sort By:
Pageof 138
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Gut|November 30, 2018
Fine needle aspirates comprehensively sample intrahepatic immunityUpkar S Gill, Laura J Pallett, Niclas Thomas, et al.
Journal of Virology|May 28, 2003
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12Michael B Zwick, Robert Kelleher, Richard Jensen, et al.
BMJ Open|August 28, 2016
Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventionsL Williams, J Rycroft-Malone, C R Burton, et al.
European Heart Journal|March 25, 2004
Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control studyMartin D Tobin, Peter S Braund, Paul R Burton, et al.
AIDS Research and Human Retroviruses|February 21, 2008
Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140Suganya Selvarajah, Bridget A Puffer, Fang-Hua Lee, et al.
Cell Reports|March 27, 2023
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2Joel D Allen, Dylan P Ivory, Sophie Ge Song, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2012
Pharmacokinetic interaction between boceprevir and etravirine in HIV/HCV seronegative volunteersKyle P Hammond, Pamela Wolfe, James R Burton, et al.
Journal of Virology|June 20, 2001
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12M B Zwick, L L Bonnycastle, A Menendez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicityJuan F Arias, Lisa N Heyer, Benjamin von Bredow, et al.
Pageof 138